8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-277563
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading fdmt-20260617.htm…